Global Cardiac PoC Testing Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In March 2022, Mylab Discovery Solutions launched an entire range of routine diagnostic kits and devices in both conventional and point-of-care formats, including devices and kits for immunology, biochemistry, and hematology. With this launch, the company enabled laboratories to use its devices and reagent kits to perform all routine tests, such as liver panels, cardiac profiles, urine panels, hormone panels, and other tests.

• In January 2022, MEDLAB Middle East showcased its portfolio of life-changing diagnostic tools and medical devices for point-of-care testing that helped manage patients with COVID-19, diabetes, cardiovascular disease, and comorbidities.

The global cardiac Point-of-Care (PoC) testing devices market encompasses a diverse range of product types, with cardiac markers tests and analyzers emerging as key categories driving innovation and efficiency in cardiovascular diagnostics. Cardiac markers tests play a pivotal role in the rapid detection and monitoring of cardiac conditions by measuring biomarkers such as troponin, creatine kinase-MB (CK-MB), and myoglobin. These tests enable healthcare providers to swiftly assess cardiac health and make informed decisions regarding patient management and treatment strategies. On the other hand, analyzers form the backbone of PoC testing infrastructure, offering the technological sophistication necessary for accurate and reliable measurement of cardiac biomarkers at the point of care. With advancements in miniaturization and automation, analyzers are evolving to deliver enhanced performance, portability, and user-friendliness, catering to the diverse needs of healthcare settings worldwide.

Across the healthcare continuum, a multitude of end users rely on cardiac PoC testing devices to support their diagnostic and monitoring needs. Research laboratories serve as hotbeds of innovation, driving advancements in cardiac biomarker testing methodologies and contributing to the development of next-generation PoC devices. Hospitals, as primary hubs of patient care, deploy PoC testing devices to expedite clinical decision-making, enhance workflow efficiency, and improve patient outcomes.

Ambulatory surgical centers leverage PoC testing technology to facilitate preoperative assessment, intraoperative monitoring, and postoperative care, ensuring the safety and well-being of patients undergoing cardiac procedures. Diagnostic laboratories, equipped with sophisticated instrumentation and skilled personnel, utilize PoC testing devices to augment their testing portfolios, offering rapid turnaround times and comprehensive cardiovascular testing services. Additionally, other healthcare settings, including clinics, emergency departments, and home healthcare environments, integrate PoC testing devices into their practice to meet the growing demand for convenient, accessible, and high-quality cardiac diagnostics. As the landscape of cardiovascular care continues to evolve, stakeholders across various end-user segments are poised to drive the adoption and expansion of the global cardiac PoC testing devices market, shaping the future of cardiovascular diagnostics and patient care.

Global Cardiac PoC Testing Devices Segment Analysis

In this report, the Global Cardiac PoC Testing Devices Market has been segmented by Product Type, End User, and Geography.

Global Cardiac PoC Testing Devices Market, Segmentation by Product Type

The Global Cardiac PoC Testing Devices Market has been segmented by Product Type into Cardiac Markers Test, and Analyzers.

The segmentation of the Global Cardiac PoC Testing Devices Market by product type into Cardiac Markers Test and Analyzers reflects the diverse technological landscape driving advancements in cardiovascular diagnostics. Cardiac markers tests serve as frontline tools for rapid and precise detection of cardiac biomarkers, enabling healthcare professionals to swiftly assess cardiac health and make informed clinical decisions. These tests, which measure biomarkers like troponin, CK-MB, and myoglobin, play a crucial role in early diagnosis, risk stratification, and monitoring of cardiac conditions, ultimately enhancing patient outcomes and reducing healthcare burdens. In parallel, analyzers form the backbone of PoC testing infrastructure, offering sophisticated instrumentation and automation to facilitate accurate and reliable measurement of cardiac biomarkers at the point of care. With continuous innovations in miniaturization, connectivity, and user interface design, analyzers are evolving to meet the demands of diverse healthcare settings, ranging from hospitals and clinics to ambulatory care centers and research laboratories.

The Cardiac Markers Test segment of the market is characterized by a growing demand for rapid, sensitive, and specific diagnostic assays capable of detecting subtle changes in cardiac biomarker levels. These tests enable timely intervention and risk stratification for patients presenting with symptoms of acute coronary syndrome, heart failure, and other cardiovascular conditions. As the global burden of cardiovascular diseases continues to escalate, fueled by factors such as aging populations, sedentary lifestyles, and rising prevalence of risk factors like obesity and diabetes, there is an increasing emphasis on preventive healthcare and early disease detection, driving the adoption of cardiac markers tests across healthcare settings worldwide.

The Analyzers segment of the market is witnessing rapid technological advancements aimed at enhancing performance, portability, and usability. From compact handheld devices to fully automated benchtop systems, analyzers offer a diverse range of solutions tailored to the needs of clinicians, laboratory professionals, and point-of-care providers. These analyzers integrate innovative features such as rapid turnaround times, intuitive user interfaces, and connectivity options, enabling seamless integration into existing healthcare workflows and enhancing overall efficiency. With the growing trend towards decentralized healthcare delivery models and the increasing importance of personalized medicine, analyzers are poised to play a pivotal role in shaping the future of cardiovascular diagnostics, driving innovation and improving patient care across the globe.

Global Cardiac PoC Testing Devices Market, Segmentation by End User

The Global Cardiac PoC Testing Devices Market has been segmented by End User into Research Laboratories, Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others.

Segmentation of the Global Cardiac PoC Testing Devices Market by end user into Research Laboratories, Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others highlights the diverse landscape of healthcare settings leveraging these innovative diagnostic solutions. Research Laboratories serve as crucibles for innovation, driving advancements in cardiac biomarker testing methodologies and contributing to the development of next-generation PoC devices. These facilities play a vital role in validating new technologies, refining assay performance, and exploring novel biomarkers, ultimately shaping the future of cardiovascular diagnostics.

Hospitals, as primary hubs of patient care, are at the forefront of adopting PoC testing devices to expedite clinical decision-making, enhance workflow efficiency, and improve patient outcomes. PoC testing enables rapid assessment of cardiac biomarkers in emergency departments, intensive care units, and cardiology wards, facilitating timely intervention for patients presenting with acute coronary syndrome, heart failure, and other cardiovascular conditions. With the growing emphasis on value-based care and the importance of early disease detection, hospitals are increasingly relying on PoC testing devices to streamline diagnostic pathways and optimize resource utilization.

Ambulatory Surgical Centers (ASCs) represent a burgeoning segment of the market, leveraging PoC testing technology to support preoperative assessment, intraoperative monitoring, and postoperative care for patients undergoing cardiac procedures. These outpatient facilities benefit from the portability, speed, and accuracy of PoC testing devices, enabling rapid risk stratification and perioperative management. By integrating PoC testing into their practice, ASCs enhance patient safety, minimize procedural complications, and improve overall surgical outcomes. As healthcare delivery continues to evolve towards decentralized models, ASCs are poised to play an increasingly prominent role in driving the adoption and expansion of cardiac PoC testing devices, transforming the landscape of cardiovascular care.

Global Cardiac PoC Testing Devices Market, Segmentation by Geography

In this report, the Global Cardiac PoC Testing Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Cardiac PoC Testing Devices Market Share (%), by Geographical Region, 2024

The segmentation of the Global Cardiac PoC Testing Devices Market by Geography into five regions—North America, Europe, Asia Pacific, Middle East and Africa, and Latin America—provides valuable insights into the regional dynamics shaping the adoption and growth of cardiovascular diagnostics. North America emerges as a key market leader, driven by factors such as the presence of advanced healthcare infrastructure, high healthcare expenditure, and a significant burden of cardiovascular diseases. The region benefits from robust regulatory frameworks, extensive research and development activities, and strong collaborations between industry players and healthcare institutions, fostering innovation and market expansion.

In Europe, the adoption of cardiac PoC testing devices is propelled by a growing emphasis on preventive healthcare, early disease detection, and personalized medicine. The region boasts a diverse healthcare landscape characterized by universal healthcare coverage, well-established laboratory networks, and a proactive approach towards healthcare innovation. With increasing efforts to optimize healthcare delivery, reduce hospital admissions, and improve patient outcomes, European countries are investing in PoC testing technologies to enhance diagnostic capabilities, streamline clinical workflows, and address the evolving needs of cardiovascular care.

In the Asia Pacific region, rapid urbanization, demographic shifts, and rising disposable incomes are driving the demand for advanced healthcare solutions, including cardiac PoC testing devices. Countries such as China, India, and Japan are witnessing significant investments in healthcare infrastructure, coupled with initiatives to expand access to essential healthcare services in rural and underserved areas. PoC testing devices offer a cost-effective and scalable solution to address the growing burden of cardiovascular diseases, enabling timely diagnosis, risk stratification, and management. With supportive government policies, increasing healthcare spending, and a growing focus on healthcare quality and accessibility, the Asia Pacific region presents lucrative opportunities for market players looking to expand their presence and tap into emerging markets.

In the Middle East and Africa, and Latin America regions, the adoption of cardiac PoC testing devices is influenced by factors such as improving healthcare infrastructure, rising awareness about cardiovascular health, and increasing investments in healthcare modernization. Despite challenges related to healthcare access and resource constraints, these regions are witnessing steady growth in demand for PoC testing solutions, driven by efforts to enhance healthcare delivery, reduce disease burden, and improve patient outcomes. As stakeholders collaborate to address healthcare disparities, expand access to essential diagnostics, and strengthen healthcare systems, the market for cardiac PoC testing devices is poised to witness sustained growth and diversification across diverse geographic regions.

This report provides an in depth analysis of various factors that impact the dynamics of Global Cardiac PoC Testing Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Aging Population
• Increasing Cardiovascular Diseases

• Demand for Rapid Diagnosis - The demand for rapid diagnosis in the Global Cardiac PoC Testing Devices Market stems from the critical need to expedite clinical decision-making and improve patient outcomes. With cardiovascular diseases posing significant health risks worldwide, there is a growing emphasis on timely intervention and treatment initiation. Rapid diagnosis enables healthcare providers to swiftly assess cardiac health, stratify patient risk, and implement appropriate management strategies, reducing the time to diagnosis and facilitating prompt initiation of therapy. By leveraging PoC testing devices capable of delivering rapid results at the point of care, clinicians can expedite diagnostic workflows, optimize resource utilization, and enhance patient satisfaction, ultimately leading to improved clinical outcomes and reduced healthcare burdens.

  The demand for rapid diagnosis is further fueled by the increasing prevalence of acute cardiovascular conditions, such as acute coronary syndrome and heart failure, which require prompt evaluation and intervention to prevent adverse outcomes. Rapid diagnostic tests for cardiac biomarkers, such as troponin and CK-MB, enable early detection of myocardial injury or infarction, allowing clinicians to initiate appropriate treatments, such as reperfusion therapy or antiplatelet agents, in a timely manner. By facilitating rapid risk stratification and treatment triage, PoC testing devices empower healthcare providers to deliver timely and targeted care, thereby improving patient outcomes and reducing morbidity and mortality associated with acute cardiac events.

  The demand for rapid diagnosis is driven by the evolving healthcare landscape, characterized by a shift towards decentralized care delivery models and patient-centric approaches. PoC testing devices offer the advantage of delivering actionable results in real time, directly at the patient's bedside, in outpatient settings, or even in remote or resource-limited environments. By enabling rapid diagnosis outside traditional laboratory settings, these devices empower clinicians to make informed decisions quickly, facilitate early interventions, and improve patient access to timely and high-quality care. As healthcare systems strive to enhance efficiency, accessibility, and patient satisfaction, the demand for rapid diagnosis using PoC testing devices is expected to continue growing, driving innovation and investment in the global cardiac PoC testing devices market.

Restraints:

• Reimbursement Issues
• High Cost of Devices

• Limited Access to Healthcare - Limited access to healthcare presents a significant challenge in the global landscape of cardiac Point-of-Care (PoC) testing devices, particularly in underserved and remote regions where healthcare infrastructure is lacking or inadequate. The disparity in access to healthcare services disproportionately affects vulnerable populations, including low-income individuals, rural communities, and marginalized groups, exacerbating existing disparities in cardiovascular care. Limited access to healthcare facilities, diagnostic services, and trained healthcare professionals hinders timely diagnosis and management of cardiovascular diseases, leading to poorer health outcomes and increased morbidity and mortality.

  In regions with limited access to healthcare, PoC testing devices have the potential to bridge the gap by bringing diagnostic capabilities closer to the point of need. Portable and user-friendly PoC devices enable decentralized testing in community clinics, mobile health units, and remote healthcare settings, facilitating timely diagnosis and treatment initiation for patients with cardiovascular conditions. By providing rapid and reliable diagnostic results outside traditional laboratory settings, PoC testing devices empower frontline healthcare workers to deliver essential cardiovascular care in resource-limited environments, improving access to timely diagnosis and reducing disparities in healthcare delivery.

  However, addressing limited access to healthcare requires a multifaceted approach that goes beyond the provision of PoC testing devices alone. It necessitates investments in healthcare infrastructure, capacity building, and health system strengthening to ensure equitable access to comprehensive cardiovascular services. Collaborative efforts involving governments, healthcare organizations, non-governmental organizations, and industry stakeholders are essential to address systemic barriers to healthcare access, improve health literacy, and enhance the reach and impact of PoC testing devices in underserved communities. By leveraging technology, innovation, and strategic partnerships, the global healthcare community can work towards overcoming the challenges of limited access to healthcare and advancing cardiovascular care for all, irrespective of geographical location or socioeconomic status.

Opportunities:

• Personalized Medicine
• Remote Patient Monitoring

• Point-of-Care Testing Expansion - The expansion of point-of-care (PoC) testing represents a transformative shift in the delivery of healthcare services, offering numerous benefits in the context of cardiac diagnostics. PoC testing enables rapid and convenient access to diagnostic information at or near the point of patient care, reducing the time to diagnosis and facilitating prompt treatment decisions. In the realm of cardiovascular care, PoC testing devices play a crucial role in the early detection, risk stratification, and monitoring of cardiac conditions, offering clinicians actionable insights in real time. As healthcare systems worldwide recognize the importance of timely intervention and personalized medicine, the expansion of PoC testing is becoming increasingly integral to improving patient outcomes and enhancing healthcare efficiency.

  The growing demand for PoC testing expansion is driven by several factors, including the need for streamlined diagnostic workflows, improved patient satisfaction, and enhanced resource utilization. By bringing diagnostic testing closer to the patient, PoC testing devices minimize delays associated with sample transportation, processing, and result reporting, enabling clinicians to make informed decisions quickly and efficiently. This streamlined approach not only improves the efficiency of healthcare delivery but also enhances the patient experience by reducing wait times and facilitating timely access to care. Additionally, PoC testing expansion enables healthcare providers to optimize resource allocation, reduce unnecessary hospital admissions, and mitigate healthcare costs, ultimately leading to improved healthcare outcomes and greater healthcare system sustainability.

  Advancements in technology and innovation are driving the expansion of PoC testing capabilities, enabling the development of increasingly sophisticated and user-friendly testing devices. Miniaturization, automation, and connectivity features allow PoC testing devices to deliver rapid and accurate results with minimal user intervention, making them well-suited for use in diverse healthcare settings, including hospitals, clinics, ambulatory care centers, and community outreach programs. As PoC testing continues to evolve and diversify, with the integration of novel biomarkers, multiplexing capabilities, and remote monitoring functionalities, the potential applications for cardiac diagnostics expand, offering new opportunities to improve patient care and advance the field of cardiovascular medicine. In summary, the expansion of PoC testing represents a paradigm shift in healthcare delivery, with profound implications for cardiac diagnostics, patient care, and healthcare system efficiency, driving innovation and transformative change in the global healthcare landscape.